Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Stanford University
Ensem Therapeutics
Varian, a Siemens Healthineers Company
PMV Pharmaceuticals, Inc
Kivu Bioscience Inc.
FindCure Biosciences (ZhongShan) Co., Ltd.
Hoffmann-La Roche
UMC Utrecht
AstraZeneca
University of Chicago
University of California, Irvine
Eastern Cooperative Oncology Group
Eli Lilly and Company
ViroMissile, Inc.
EMD Serono
Terremoto Biosciences Inc.
Hospices Civils de Lyon
University Health Network, Toronto
Jazz Pharmaceuticals
Kaiser Permanente
Duke University
Washington University School of Medicine